Abstract Objective To explore the roles of PKCβ/P66Shc oxidative stress signal pathway in mediating hyperoxia-induced reactive oxgen species (ROS) production in alveolar epithelial cells (A549) and the protective effects of PKCβ inhibitor on hyperoxia-induced injuries of alveolar epithelial cells. Methods A549 cells were cultured in vitro and randomly divided into three groups: control, hyperoxia and PKCβ inhibitor LY333531 treatment. The hyperoxia group was exposed to a mixture of O2 (950 mL/L) and CO2 (50 mL/L) for 10 minutes and then cultured in a closed environment. The LY333531 group was treated with PKCβ inhibitor LY333531 of 10 μmol/L for 24 hours before hyperoxia induction. Cells were collected 24 hours after culture and the levels of PKCβ, Pin1, P66Shc and P66Shc- Ser36 were detected by Western blot. The intracellular translocation of P66Shc, the production of ROS and cellular mitochondria membrane potential were measured using the confocal microscopy. Results Compared with the control group, the levels of PKCβ, Pin1, P66Shc and P-P66Shc-Ser36 in A549 cells 24 hours after culture increased significantly in the hyperoxia group. These changes in the hyperoxia group were accompanied with an increased translocation rate of P66Shc from cytoplasm into mitochondria, an increased production of mitochondrial ROS, and a reduced mitochondrial membrane potential. Compared with the hyperoxia group, the levels of Pin1, P66Shc and P66Shc-Ser36 in A549 cells, the translocation rate of P66Shc from cytoplasm into mitochondria and the production of mitochondrial ROS decreased significantly, while the mitochondrial membrane potential increased significantly in the LY333531 treatment group. However, there were significant differences in the above mentioned measurements between the LY333531 treatment and control groups. Conclusions Hyperoxia can increase the expression of PKCβ in alveolar epithelial cells and production of mitochondrial ROS and decrease mitochondrial membrane potential. PKCβ inhibitor LY333531 can partially disrupt these changes and thus alleviate the hyperoxia-induced alveolar epithelial cell injury.
About author:: 10.7499/j.issn.1008-8830.2015.03.016
Cite this article:
CHE Zhong-Li,DONG Wen-Bin,LI Qing-Ping et al. Roles of PKCβ/P66Shc oxidative stress signal pathway in mediating hyperoxiainduced ROS production in alveolar epithelial cells[J]. CJCP, 2015, 17(3): 275-280.
CHE Zhong-Li,DONG Wen-Bin,LI Qing-Ping et al. Roles of PKCβ/P66Shc oxidative stress signal pathway in mediating hyperoxiainduced ROS production in alveolar epithelial cells[J]. CJCP, 2015, 17(3): 275-280.
Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia [J]. Curr Opin Pediatr, 2011, 23(3): 305-313.
[2]
Chetty A, Cao GJ, Manzo N, et al. The role of IL-6 and IL-11 in hyperoxic injury in developing lung [J]. Pediatr Pulmonol, 2008, 43(3): 297-304.
[3]
Ilizarov AM, Koo HC, Kazzaz JA, et al. Overexpression of manganese superoxide dismutase protects lung epithelial cells against oxidant injury [J]. Am J Respir Cell Mol Biol, 2001, 24(4): 436-441.
[4]
Gore A, Muralidhar M, Espey MG, et al. Hyperoxia sensing: from molecular mechanisms to significance in disease [J]. J Immunotoxicol, 2010, 7(4): 239-254.
[5]
Kardeh S, Ashkani-Esfahani S, Alizadeh AM. Paradoxical action of reactive oxygen species in creation and therapy of cancer [J]. Eur J Pharmacol, 2014, 735: 150-168.
[6]
Ratner V, Starkov A, Matsiukevich D, et al. Mitochondrial dysfunction contributes to alveolar developmental arrest in hyperoxia-exposed mice [J]. Am J Respir Cell Mol Biol, 2009, 40(5): 511-518.
[7]
Pagano A, Donati Y, Metrailler I, et al. Mitochondrial cytochrome c release is a key event in hyperoxia-induced lung injury: protection by cyclosporin A [J]. Am J Physiol Lung Cell Mol Physiol, 2004, 286(2): L275-283.
[8]
Waxman AB, Kolliputi N. IL-6 protects against hyperoxiainduced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins [J]. Am J Respir Cell Mol Biol, 2009, 41(4): 385-396.
[9]
Lee TH, Pastorino L, Lu KP. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease [J]. Expert Rev Mol Med, 2011, 13: e21.
Pinton P, Rimessi A, Marchi S, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant P66Shc [J]. Science, 2007, 315(5812): 659-663.
Ricci C, Pastukh V, Leonard J, et al. Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis [J]. Am J Physiol Cell Physiol, 2008, 294(2): C413- 422.
[14]
Hanes SD. The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle [J]. Biochim Biophys Acta, 2014, 1839(4): 316-333.
[15]
Delavallee L, Cabon L, Galan-Malo P, et al. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics [J]. IUBMB Life, 2011, 63(4): 221-232.
[16]
Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and P66Shc generates reactive oxygen species that trigger mitochondrial apoptosis [J]. Cell, 2005, 122(2): 221-233.
